UBS Group’s ETRACS 2x Leveraged MSCI US Quality Factor TR ETN QULL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-97
Closed -$4.75K 10815
2025
Q2
$4.75K Hold
97
﹤0.01% 9245
2025
Q1
$4.25K Sell
97
-12
-11% -$580 ﹤0.01% 9125
2024
Q4
$5.25K Buy
+109
New +$5.5K ﹤0.01% 8684
2024
Q3
Sell
-101
Closed -$4.58K 9962
2024
Q2
$4.58K Sell
101
-3
-3% -$127 ﹤0.01% 8073
2024
Q1
$4.43K Hold
104
﹤0.01% 7626
2023
Q4
$3.63K Sell
104
-832
-89% -$25.9K ﹤0.01% 7941
2023
Q3
$26.5K Sell
936
-1,950
-68% -$59.6K ﹤0.01% 6656
2023
Q2
$87K Buy
+2,886
New +$77.9K ﹤0.01% 6123
2023
Q1
Sell
-47
Closed -$1.04K 10238
2022
Q4
$1.04K Hold
47
﹤0.01% 9977
2022
Q3
$1K Hold
47
﹤0.01% 10015
2022
Q2
$1K Buy
+47
New +$1.25K ﹤0.01% 9943

UBS Group's QULL Position: Q3 2025 in Review

UBS Group sold out of ETRACS 2x Leveraged MSCI US Quality Factor TR ETN (QULL) in Q3 2025, closing a stake of 97 shares — an estimated $4.75K sold.

UBS Group first reported a position in QULL in Q2 2022 and held it in 11 quarters. The position peaked at $87K in Q2 2023. 0 funds tracked by Wall St. Rank hold QULL as of Q3 2025.

  • UBS Group reported no remaining ETRACS 2x Leveraged MSCI US Quality Factor TR ETN position as of Q3 2025 after selling out during the quarter.
  • UBS Group sold 97 ETRACS 2x Leveraged MSCI US Quality Factor TR ETN shares in Q3 2025, an estimated $4.75K.
  • UBS Group first reported a position in ETRACS 2x Leveraged MSCI US Quality Factor TR ETN in Q2 2022 and held it in 11 quarters.
  • UBS Group's ETRACS 2x Leveraged MSCI US Quality Factor TR ETN position peaked at $87K in Q2 2023.
  • 0 funds tracked by Wall St. Rank held ETRACS 2x Leveraged MSCI US Quality Factor TR ETN as of Q3 2025.

Based on UBS Group's 13F filing for Q3 2025, filed 13 Nov 2025.